EdU, a new thymidine analogue for labelling proliferating cells in the nervous system by Chehrehasa, Fatemeh et al.
This is the author’s version of a work that was submitted/accepted for pub-
lication in the following source:
Chehrehasa, Fatemeh, Meedeniya, Adrian C.B., Dwyer, Patrick, Abraham-
sen, Greger, & Mackay-Sim, Alan (2009) EdU, a new thymidine analogue
for labelling proliferating cells in the nervous system. Journal of Neuro-
science Methods, 177 (1), pp. 122-130.
This file was downloaded from: http://eprints.qut.edu.au/69879/
c© Copyright 2009 Elsevier
This is the author’s version of a work that was accepted for publication in
Journal of Neuroscience Methods. Changes resulting from the publish-
ing process, such as peer review, editing, corrections, structural format-
ting, and other quality control mechanisms may not be reflected in this
document. Changes may have been made to this work since it was sub-
mitted for publication. A definitive version was subsequently published
in Journal of Neuroscience Methods, [VOL 177, ISSUE 1, (2009)] DOI:
10.1016/j.jneumeth.2008
Notice: Changes introduced as a result of publishing processes such as
copy-editing and formatting may not be reflected in this document. For a
definitive version of this work, please refer to the published source:
http://dx.doi.org/10.1016/j.jneumeth.2008.10.006
 1
EdU, a new thymidine analogue for labelling proliferating cells in the nervous 
system 
 
Fatemah Chehrehasa, Adrian C. B. Meedeniya, Patrick Dwyer, Greger Abrahamsen, 
Alan Mackay-Sim *  
 
 
 
Fatemah Chehrehasa and Adrian C. B. Meedeniya are co-first authors. 
 
 
 
 
 
 
 
 
Number of pages: 16, number of figures: 6, number of tables: 1. 
 
 
 
 
 
 
 
 
Address for correspondence: 
 
Professor Alan Mackay-Sim  
Director, National Centre for Adult Stem Cell Research 
Eskitis Institute for Cellular & Molecular Therapies 
Griffith University 
Brisbane, Qld 4111 
Australia 
 
Email: a.mackay-sim@griffith.edu.au 
Phone: +61 7 3735 4233 
Fax: +61 7 3735 4255 
 
 
Total words of text: 2352
 2
Abstract 
(192 words) 
The standard method of labelling proliferating cells uses the thymidine analogue, 
bromodeoxyuridine (BrdU), which incorporates into the DNA during S-phase of the 
cell cycle. A disadvantage of this method is that the immunochemical processing 
requires pre-treatment of the cells and tissue with heat or acid to reveal the antigen. 
This pre-treatment reduces reliability of the method and degrades the specimen, 
reducing the ability for multiple immuno-fluorescence labelling at high resolution. 
We report here the utility of a novel thymidine analogue, ethynyl deoxyuridine (EdU), 
detected with a fluorescent azide via the “click” chemistry reaction (the Huisgen 1,3-
dipolar cycloaddition reaction of an organic azide to a terminal acetylene). The 
detection of EdU requires no heat or acid treatment and the incorporated EdU is 
covalently conjugated to fluorescent probe. The reaction is quick and compatible with 
fluorescence immunochemistry and other fluorescent probes. We show here that EdU 
is non-toxic in vitro and in vivo and can be used in place of BrdU to label cells during 
neurogenesis and the progeny identified at least 30 days later. The fluorescent 
labelling of EdU, markedly improves the detection of proliferating cells and allows 
concurrent high resolution fluorescence immunochemistry.   
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Introduction  
 
(409 wds) 
 
With the recognition that neurogenesis continues to occur in the adult brain, including 
human brain (Eriksson et al., 1998), the interest in labelling dividing cells in the 
nervous system has grown rapidly in the last 20 years. Historically, the first method 
involved the incorporation of [3]H-thymidine into DNA during S-phase of the cell 
cycle (Swierkowska et al., 1973). This method is very useful for quantitative analyses 
of cell division but has shortcomings due to the labour-intensive and time-consuming 
processing required for detecting the radioactivity (Taupin, 2007). Radioactive 
methods are also not compatible with modern high-resolution microscopy because the 
emulsion used to detect the label lies outside the plane of focus of the labelled DNA. 
Currently, the method of choice to label dividing cells is the incorporation of  5-
bromo-2’-deoxyuridine (BrdU), a thymidine analogue that is detected with a BrdU-
specific antibody (Dean et al., 1984; Nagashima et al., 1985; Miller and Nowakowski, 
1988; Takamiya et al., 1988; Tang et al., 2007). This method is much more 
convenient than the former method and is compatible with high resolution 
microscopic methods, including immunochemistry. The major disadvantage of BrdU 
is that the epitope is masked within the DNA and strong denaturing conditions, such 
as strong acids and heating, are required to reveal it. This introduces significant 
variability in the results obtained, within and between experiments. A major 
shortcoming is the loss of structure and loss of other antigens in the tissue, reducing 
the efficacy for high resolution microscopy. Loss of antigens may be overcome using 
antigen retrieval methods (Tang et al., 2007) but these require further acid and heat 
treatment that can further degrade cellular structure. We describe here a method of 
labelling cells with an alternate thymidine analogue, 5-ethynyl-2’-deoxyuridine (EdU) 
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in which the terminal methyl group is replaced with an alkyne group. Detection of this 
compound is achieved using a fluorescent azide that covalently binds to the alkyne 
group in a reaction known as “click chemistry” (Tornoe et al., 2002; Sawa et al., 
2006; Hsu et al., 2007) (Fig. 1). This detection method does not require DNA 
denaturation and is compatible with other DNA labelling techniques. It is fast and 
specific, with little background because of the specificity of the copper-catalysed 
“click” reaction. We show here that EdU is incorporated into dividing cells in vitro 
and in vivo, including in utero. It can be used to birth-date cells and can be followed 
in vivo for at least 30 days. Most importantly it is compatible with high-resolution 
multiple immunofluorescence.  
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Materials and Methods    (957 wds) 
EdU chemistry 
The 50 assay Click-iT™ EdU Cell Proliferation Assay Kit (Cat# C35002, Invitrogen) 
contains 12 reagents named component A to component L. Components A, B, E, G, H 
and I are required. The component description as provided by the supplier: 
Component A, EdU: Component B, Alexa Fluor® 488 azide; E, saponin-based 
permabilization and wash reagent; G, reaction buffer; H, copper sulphate; I, buffer 
additive. Cells or tissue sections were incubated in component E for 30 minutes on a 
rocker, followed by incubation with the reaction cocktail for 30 minutes at RT, 
protected from light. 1500μl of reaction cocktail contained 7.5μl of component B, 
30μl of component H, 1314μl of a 1X component G and 150μl of a 1X component I. 
The cells or sections were washed for 3X5 minutes in component E and cover slipped 
using Vectashield DAPI (4′6-diamidino-2-phenylindole·2HCl, Vector Labs) 
mounting media which labels cell nuclei. The reaction cocktail was used within 15 
minutes of preparation. 
 
EdU in vitro 
Neurospheres were derived from human olfactory mucosa (Murrell et al, 2005). The 
cells were passaged using trypsin (Invitrogen), and seeded in medium (DMEM/F12 
with 10% FBS and 1% penicillin/streptomycin) onto 8 well plastic chambers slides 
(Nunc) at a concentration of 10,000 cells/cm2. The cells were grown overnight in 
medium (DMEM/F12 with 10% FBS and 1% penicillin/streptomycin) in a humidified 
incubator at 37°C with 5% CO2. The cells were then grown for 24 hr in medium 
containing EdU at different concentrations (1μM-20μM). Cells were fixed in 4% 
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paraformaldehyde in phosphate buffered saline (pH 7.4; PBS). The EdU positive cells 
were labelled with the fluorescent azide probe (see above), followed by 
immunofluorescence for anti-Actin. All cell nuclei were counterstained with DAPI. 
Three fields were analysed for each EdU concentration and the experiments were 
done in triplicate.  
 
EdU in vivo 
9 Pregnant C57B6 mice and their pups were used in the experiment. All procedures 
were carried out with the approval of the Griffith University Animal Ethics 
Committee under the guidelines of the National Health and Medical Research Council 
of Australia. For acute labelling post-partum, Group 1 received a single 
intraperitoneal injection of combining both BrdU and EdU at post-natal day 1 (P1) 
and euthanized at P2  to harvest tissues. For acute labelling in utero, Group 2 pregnant 
dams received an intraperitoneal injection of EdU at embryonic day 20 (E20) and the 
pups were killed at P0. For long term labelling post-partum, Group 3 pregnant dams 
received an intraperitoneal injection of BrdU at E16, the pups were given an 
intraperitoneal injection of EdU in P7 and then killed at P30. EdU (5-ethyl-2’-
deoxyuridine , Invitrogen, Australia Pty Ltd) and BrdU (5-bromo-29- deoxyuridine, 
Sigma B 5002, St. Louis, MO) were given at a dose of 50 mg/kg body weight in a 
solution of 10 mg/ml  PBS (pH 7.35) for EdU and 20 mg/ml in PBS for BrdU. 
 
Tissue fixation and preparation   
Mice were killed by cervical dislocation and the heads fixed by immersion in 4% 
paraformaldehyde in PBS at room temperature for 2 hr (P0, P2) or 4 hr (P30). 
Following fixation, the P30 heads were decalcified in 20% disodium ethylene 
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diaminetetraacetic acid (EDTA) in PBS. The heads were placed in an embedding 
matrix (O.C.T. compound, Miles Scientific, Naperville, IL) and snap frozen by 
immersion in iso-pentane that had been cooled with liquid nitrogen. Cryostat sections 
(18 m) of the nasal cavity and brain were cut, mounted on to gelatinized slides and 
stored at –20oC before processing first for EdU chemistry and then for 
immunochemistry. 
 
Tissue preparation for BrdU immunohistochemistry  
Tissue sections were pre-treated to denature DNA, before immunolabeling for BrdU 
according to our protocol which was optimised for fluorescence in situ hybridisation 
using oligonucliotide probes (Robinson et al., 2005). Firstly, sections were treated 
with 1x Pepsin (0.05mg/ml in 0.12M HCL) for 20 mins at 37°, followed by a 10 
minute wash in 5X sodium chloride-sodium citrate buffer (SSC). [A 20X stock 
solution of SSC was prepared as follows: 173.3g NaCl and 88.2g tri-Sodium Citrate 
(Cat# SA034, Chem-Supply, Pty, Ltd) were dissolved in 950 ml distilled H2O and the 
pH was adjusted to 7.4; H2O was added to bring the final volume to 1000 ml. For 5X 
and 2X SSC, the 20X SSC was diluted in distilled H2O.] Sections were then placed on 
a heating block at 95°C for 5 mins incubated in a denaturing solution, 1 ml of which 
contained: 450μl of 100% Formamide (Cat# F9037, Sigma), 250μl of 20X SSC, 
250μl of 10% chondroitin sulphate (Cat#C9819, Sigma)  25μl of ssDNA (herring 
sperm, single stranded DNA, Cat#D7290, Sigma) and 25μl of distilled H2O. After 
washing in 2X SSC for 10 minutes, the standard immuno-labelling protocols were 
applied. For detecting cells incorporating both BrdU and EdU, the protocol was 
performed in the following order: DNA denaturation, EdU chemistry, BrdU 
immunohistochemistry.  
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Immunohistochemistry 
Sections were incubated in DMSO (neat) for 15 min before being washed with 0.1M 
PBS and 0.1% Triton-X-100 (TX-100) for 2 min. They were then incubated with 10% 
normal donkey serum (NDS; Sigma Chemical Corporation) in 0.1M PBS with 0.1% 
Triton X-100 for 1 hr at room temperature. The primary antibodies used for single and 
multiple labelling are listed in Table 1. These were diluted in 10% normal donkey 
serum (NDS)/PBS/ Triton X-100 and the sections incubated overnight at room 
temperature. Sections were then washed with PBS/Triton-X-100 and incubated in the 
appropriate secondary antibody (Table 1) for 3 hrs at room temperature, washed in 
PBS/Triton X-100 and coverslipped with Vectashield  DAPI mounting medium. 
 
Image capture and image preparation  
Images were captured using an Axio Imager Z1 epi-fluorescence microscope with 
Apotome and an Axiocam Mrm camera (Carl Zeiss, Germany).  Serial optical 
sections were captured using AxioVision software and projected to provide two-
dimensional maximum brightness images. Figures were compiled in Adobe 
Photoshop 7.0 and Adobe Illustrator 10.0 (Adobe Systems Incorporated).  
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Results        (541 wds) 
 
EdU labels cells in vitro 
Cells incorporated EdU in vitro and showed intense nuclear fluorescence after 
labelling with Alexa-Fluor 488 azide (Fig 2). The detection of EdU was compatible 
with the fluorescent nuclear label, DAPI, and immunochemistry (Fig. 2 A-D). The 
fluorescent azide probe for EdU was specific, showing clear co-localisation with 
DAPI (Fig. 2D, arrowheads), with other nuclei clearly negative for EdU (Fig. 2D, 
arrow).  EdU fluorescence was located in the nucleus and not cytoplasm, identified by 
immunolabelling with anti-α actin (Fig. 2A, D).  Maximal labelling of dividing cells 
was achieved at 5μM concentration (Fig.2E) without obvious cytotoxicity. EdU did 
not effect the total cell number over the concentration range 0-20 µM (One-way 
analysis of variance, p=0.107).   
 
EdU labels cells in neurogenic brain regions 
After an intraperitoneal injection of EdU into the pregnant mother at E20, many EdU-
positive cells are seen in the brain of the pup at birth (P0). Many labelled cells were 
present in neurogenic zones such as the subventricular zone and hippocampal granular 
layer (Fig 3). Cells in the rostral migratory stream and olfactory bulb were labelled 
(Fig. 3A) as well as numerous other cells throughout multiple brain regions (Fig 3A). 
Moreover,   EdU also labelled proliferative cells of the skull and choroids plexus of 
third ventricle. The extensive co-localization of EdU with DAPI in cell nuclei of the 
RMS demonstrates the ubiquitous labelling of proliferative cells (Fig. 3B-D).   At P2, 
after intraperitoneal injection of EdU at P1, numerous cells were labelled in the 
subventricular zone (Fig. 3E-G). 21 d after peritoneal injection of EdU at P7, labelled 
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cells were detected throughout the brain. Cells in hippocampus showed clear 
localisation of EdU within nuclei (Fig. 3H-J). 
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EdU and BrdU label the same cells  
In order to confirm that EdU labels dividing cells, animals received injections of EdU 
and BrdU. EdU labelled cells in the brain were identified by their green fluorescence, 
while BrdU labelled cells were identified with an antibody to BrdU, immunostained 
red (Fig.4). At P2, 1 d after a single intraperitoneal injection with BrdU and EdU, 
dividing cells in neurogenic zones were co-labelled by the two markers. For example 
in the rostral migratory stream, EdU and BrdU labelled the same cells (Fig 4.A-D, 
arrowheads). In addition, EdU provided clearer labelling of proliferative cells in 
comparison to  BrdU (Fig. 4A-D, arrows).  After BrdU labelling of dividing cells at 
E16, followed by EdU labelling at P7, double-labelled and single-labelled cells were 
observed at P30 (Fig. 4E-H). 
 
Differentiation of neural precursors birth-dated with EdU  
Cells labelled after intraperitoneal injection of EdU in neonatal mice were identified 
in the brain at 30 days of age. As expected, EdU-positive cells differentiated into 
multiple cellular phenotypes, revealed by multiple immunofluorescent labelling. For 
example, in the olfactory epithelium, cells double-labelled with EdU included 
immature neurons (expressing β-tubulin III) and horizontal basal cells (expressing 
cytokeratin 14; Fig. 5). Other EdU positive cells were also distributed within the 
Bowman’s glands (data not shown) and within the sustentacular cell layer (Fig. 5). In 
the olfactory bulb, EdU-labelled cells were located in multiple layers including 
periglomerular cells (expressing tyrosine hydroxylase; Fig. 6A-D). Numerous EdU-
positive cells were observed in the cerebellum among the granule cells, double-
labelled with an antibody to the neuronal nuclear marker, NeuN (Fig. 6E-H).  
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Discussion                                                                          (362 wds) 
 
Our findings show that EdU labels dividing cells in vitro and in vivo. It is non-toxic at 
doses commonly used for BrdU and labels the same cells, demonstrated by double-
labelled cells in the developing brain. Like BrdU, EdU can be used to birth-date cells 
in the developing brain and follow their differentiation and migration using antibodies 
to neuronal markers such as -tubulin III, NeuN, and olfactory marker protein and 
tyrosine hydroxylase. It is compatible with immunochemistry for non-neuronal 
markers such as GFAP and cytokeratin 14. The EdU protocol is also compatible with 
DNA intercalating dyes such as DAPI. We show here that EdU chemistry can be 
combined with BrdU immunochemistry, provided care is taken with the BrdU tissue 
processing (Robinson et al., 2005; Tang et al., 2007). This will allow double DNA 
labelling to identify precursor populations undergoing multiple divisions or for cell 
cycle analysis in neurogenic regions. Because the EdU protocol maintains tissue 
structural and antigenic integrity it allows high resolution, multiple fluorescence 
microscopy to identify morphological and antigenic phenotyping of recently dividing 
cells and their progeny, followed here for 21 days. 
 
The use of EdU has several advantages over BrdU for the identification of dividing 
cells, including ease and speed of use, compatibility with multiple-labelling 
immunochemistry and microscopy and, above all, the lack of tissue degradation 
during processing that preserves antigens and tissue structure for high resolution 
fluorescence microscopy. BrdU processing requires heat and/or high acidity to 
provide access of the antibody to the antigen within the DNA. EdU does not require 
DNA denaturation because the reactive terminal acetylene group is easily accessible 
 13
to the fluorescent azide probe. This probe is small and penetrates the cell and nucleus 
without harsh treatment and can even be used in living cells (Salic and Mitchison, 
2008). The results of the denaturation protocol for BrdU are often variable, making it 
difficult to identify recently divided cells. In contrast, the EdU “click” chemistry 
provides a covalent bond that is very specific: there is no other acetylene group in the 
cell. The small size of the probe and its penetrability combined with the specificity of 
reaction, guarantees very little background when the specimen is washed 
appropriately.  
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Figure Legends 
 
Figure 1 .“Click” chemistry.  
A: The Cu(I) catalysed 1,3-dipolar cycloaddition reaction of organic azides (R1-N3) 
with terminal acetylenes (R2-≡). This “click” chemistry reaction affords exclusively 
the 1,4-disubstituted 1,2,3-triazole regioisomer. B: Click-iT™ assay by Invitrogen™. 
 
Figure 2 .EdU is detected in vitro and is non-toxic.  
After 24 hrs exposure to EdU, proliferative cells were detected. A-D: dividing cells 
immunolabelled with anti –α actin (red) and EdU (green) and DAPI (blue). 
Colocaization of EdU with DAPI was demonstrated in some cells (arrowheads) but 
not others (arrow).  E: Incubation of the cells with EdU indicated that 5μM was 
sufficient to label all the dividing cells. Scale bar: 50 m. 
 
Figure 3 .EdU is detected in neurogenic zones of the brain. 
A: Parasagittal sections through the brain at P0 after EdU incorporation at E20. 
Rostral is to the right, dorsal is to the top. Proliferative cells labelled with EdU were 
present in the cortex (CX), olfactory bulb (OB), skull (S), and the choroid plexus of 
third ventricle (3V). B-D: a higher power view of the rostral migratory stream (boxed 
region in A) showing multiple nuclei double-labelled (arrowheads) with EdU (green) 
and DAPI (blue). E-G: Section through the SVZ showing EdU labelled nuclei at P2 
after EdU injection at P1. H-J: Section through the dentate gyrus of the hippocampus 
showing EdU labelled nuclei (green) at P30 after EdU injection at P7. Scale bar: 90 
um for A and 50 um (B-J). 
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Figure 4 .EdU and BrdU label the same cells.  
A-D: Section through rostral migratory stream showing cells double labelled for EdU 
(green) and BrdU (red) at P2 after injection of both labels at P1. Proliferative cells 
(arrows) were more robustly labelled with EdU in comparison to BrdU. E-H: Section 
through olfactory epithelium showing cells double - and single-labelled for EdU 
(green) and BrdU (red) at P30 after EdU injection at P7 and BrdU injection at E16. 
Double-labelled cells are indicated by arrowheads, single-labelled cells are indicated 
by arrows. Scale bar: 20 um. 
 
Figure 5 .EdU can be used to birth-date cells and follow differentiation.  
EdU is detected in differentiated cells at P30, after injection of EdU at P7. A-H: 
Sections through the olfactory epithelium showing EdU labelled cells (green) double-
labelled (red) for β-tubulin ІІІ (A-D) or cytokeratin 14 (E-H). Double-labelled cells 
are indicated by arrowheads, single-labelled cells are indicated by arrows. Scale bar: 
20 um.  
 
Figure 6 .EdU is compatible with multiple fluorescence labelling.  
EdU is detected in differentiated cells at P30, after injection of EdU at P7. A-H: 
Sections through the olfactory bulb (A-D) and cerebellum (E-H). A-D: Showing EdU 
labelled cells (green) double-labelled for tyrosine hydroxylase (red) in the glomerulus 
(GL) of olfactory bulb. Double arrowheads indicated EdU positive cells lacking TH 
labelling. E-H: Showing cells in granule layer of the cerebellum labelled with EdU 
(green), NeuN (purple), and GFAP (red in H, double arrowhead). Double-labelled 
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cells are indicated by arrowheads, single-labelled cells are indicated by arrows. Scale 
bar: 20 um  
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